🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Monte Rosa Therapeutics, Inc.

GLUE Healthcare
$17.09 $-0.08 (-0.47%)
Market Cap: $1.37 B
Gurus Holding
1
Popularity Rank
#5016
% of Shares Held
0.98%
Net Activity (Q4 2025)
-$2.62 M

Guru Ownership Trend

Guru Analysis for Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics, Inc. (GLUE), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $13.42 M.

Top institutional holders include Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $2.62 M net outflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 9.5%.

Key Holders

Top 5 by Value

$12.31 M

Top 5 by Conviction

0.01%

Recent Activity Breakdown (Q4 2025)

+$1.06 M
Total Buy Value
New Buys 0
Additions 1
-$3.68 M
Total Sell Value
Reductions 0
Sold Out 3

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
3
Net Buyers
1

FAQs for Monte Rosa Therapeutics, Inc. (GLUE)

Major holders include Cliff Asness ($12.31 M). According to the latest reported data, 1 tracked investment managers collectively hold approximately 785,057 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $2.62 M, with 1 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 0 managers trimmed their positions, while 3 fully exited GLUE. The total reported sell value was $3.68 M.

Yes, 0 managers opened new positions in GLUE, and 1 increased their existing holdings. The total reported buy value was $1.06 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Add 9.5% 785,057 $12.31 M Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form